Theratechnologies Presented Data From A Real-world, Observational, Registry Study Demonstrating The Efficacy And Safety Of Ibalizumab In Reducing HIV RNA To Undetectable Levels In Heavily Treatment-experienced Patients With Multidrug Resistant HIV